A Case of Creutzfeldt-Jakob Disease Presenting With Depression and Anxiety by Bartlett, Kathryn B, DO et al.
Lehigh Valley Health Network
LVHN Scholarly Works
Department of Emergency Medicine
A Case of Creutzfeldt-Jakob Disease Presenting
With Depression and Anxiety
Kathryn B. Bartlett DO
Lehigh Valley Health Network, Kathryn.Bartlett@lvhn.org
Kathleen E. Kane MD
Lehigh Valley Health Network, kathleen_e.kane@lvhn.org
Bryan G. Kane MD
Lehigh Valley Health Network, bryan.kane@lvhn.org
Kevin Weaver D.O.,FACOEP
Lehigh Valley Health Network, kevin_r.weaver@lvhn.org
Gavin C. Barr Jr. MD
Lehigh Valley Health Network, Gavin.Barr_jr@lvhn.org
Follow this and additional works at: https://scholarlyworks.lvhn.org/emergency-medicine
Part of the Emergency Medicine Commons
This Poster is brought to you for free and open access by LVHN Scholarly Works. It has been accepted for inclusion in LVHN Scholarly Works by an
authorized administrator. For more information, please contact LibraryServices@lvhn.org.
Published In/Presented At
Bartlett, K. B., Kane, K. E., Kane, B, G., Weaver, K. Barr, G. C. (2019, April 9). A Case of Creutzfeldt-Jakob Disease Presenting With
Depression and Anxiety. Poster Presented at: The (FOEM) Foundation for Osteopathic Emergency Medicine Case Study Poster
Competition, Bonita Spring, FL.
© 2019 Lehigh Valley Health Network
LVHN.org
A Case of Creutzfeldt-Jakob Disease Presenting With Depression and Anxiety 
Kathryn Bartlett, DO; Kathleen E. Kane, MD1; Bryan G. Kane, MD;1 Kevin R. Weaver, DO;1 Gavin C. Barr, MD1
Department of Emergency Medicine, Lehigh Valley Hospital Health Network, Allentown, Pa.; 1University of South Florida Morsani College of Medicine
INTRODUCTION
Psychiatric complaints are common reasons for presentation to the Emergency Department (ED). 
Several reports estimate the incidence of such visits at 4-5% of all ED visits.1,2 Many patients presenting 
with psychiatric complaints are otherwise healthy; however, it is common practice for the ED to 
determine if a patient is medically stable for psychiatric admission.
REFERENCES
1  Barratt H, Rojas-García A, Clarke K, et al. Epidemiology of Mental Health Attendances at Emergency Departments: Systematic Review and Meta-Analysis. PLoS 
One. 2016;11(4):e0154449. Published 2016 Apr 27. doi:10.1371/journal.pone.0154449
2  Centers for Disease Control and Prevention (CDC). Emergency department visits by patients with mental health disorders--North Carolina, 2008-2010. MMWR 
Morb Mortal Wkly Rep. 2013;62(23):469-72.
3  Gorkem, et al. Creutzfeldt-Jakob disease. Psychogeriatrics. 2011;11:119-124. Doi: 10.111/j.14779-8301.2011.00361.
4  Miyake, K., Hara, T., Oshima, E., et al. Creutzfeldt-Jakob disease with Alzheimer pathology, presenting with status epilepticus following repeated partial seizures: a 
case report and literature review. BMC Neurology. 2018;18(1). doi:10.1186/s12883-018-1055-y
5  Centers for Disease Control and Prevention (CDC). Diagnostic Criteria | Creutzfeldt-Jakob Disease, Classic (CJD) | Prion Disease | (2018, October 2). Retrieved 
from https://www.cdc.gov/prions/cjd/diagnostic-criteria.html
6  Mead S, Rudge P. CJD mimics and chameleons. Pract Neurol. 2017;17(2):113-121.
7  Anuja P, Venugopalan V, Darakhshan N, et al. Rapidly progressive dementia: An eight year (2008-2016) retrospective study. PLoS One. 2018;13(1):e0189832. 
Published 2018 Jan 18. doi:10.1371/journal.pone.0189832
8  Rosenbloom MH, Atri A. The evaluation of rapidly progressive dementia. Neurologist. 2011;17(2):67-74.
9  GENÇER, A. G., PELIN, Z., KÜÇÜKALI, C. I., et al. Creutzfeldt-Jakob disease. Psychogeriatrics. 2011; 11(2), 119-124. doi:10.1111/j.1479-8301.2011.00361.x
10  Cambier, D. M., Kantarci, K., Worrell, G. A., et al. Lateralized and focal clinical, EEG, and FLAIR MRI abnormalities in Creutzfeldt–Jakob disease. Clinical 
Neurophysiology. 2013; 114(9), 1724-1728. doi:10.1016/s1388-2457(03)00109-3
11  Manix, M., Kalakoti, P., Henry, M., et al. Creutzfeldt-Jakob disease: updated diagnostic criteria, treatment algorithm, and the utility of brain biopsy. Neurosurgical 
Focus. 2015; 39(5), E2. doi:10.3171/2015.8.focus15328
PHYSICAL EXAM
•  Normal vitals signs.
•  He is a thin, Caucasian male appearing disheveled although is 
normocephalic and atraumatic. 
•  Cranial nerves are intact; neurologic examination is normal other than 
slow, tangential speech. 
•  The heart has a regular rate and rhythm with intact distal pulses. 
•  Breath sounds and respiratory effort are normal. 
•  The abdominal examination is normal. 
•  There is no rash. 
•  The patient reports suicidal ideation with plan.
TABLE 1: WHO CRITERIA FOR DIAGNOSIS 
1. SPORADIC CJD
Rapidly progressive dementia; and at least two out of the following four clinical features:
1.  Myoclonus
2.  Visual or cerebellar signs
3.  Pyramidal/extrapyramidal signs
4.  Akinetic mutism
AND a positive result on at least one of the following laboratory tests:
•  a typical EEG (periodic sharp wave complexes) 
during an illness of any duration; and/or
•  a positive 14-3-3 cerebrospinal fluid (CSF)  
assay in patients with a disease duration of  
less than 2 years
•  Magnetic resonance imaging (MRI) high signal 
abnormalities in caudate nucleus and/or 
putamen on diffusion-weighted imaging (DWI)  
or fluid attenuated inversion recovery (FLAIR)
AND without routine investigations indicating an alternative diagnosis.
Possible: Progressive dementia; and at least two out of the following four clinical features:
1.  Myoclonus
2.  Visual or cerebellar signs
3.  Pyramidal/extrapyramidal signs
4.  Akinetic mutism
AND  the absence of a positive result for any of the three laboratory tests that would classify a 
case as “probable” (see tests a-c above)
AND duration of illness less than two years
AND without routine investigations indicating an alternative diagnosis.
2. IATROGENIC CJD
Progressive cerebellar syndrome in a recipient of human cadaveric-derived pituitary hormone;  
or sporadic CJD with a recognized exposure risk, e.g., antecedent neurosurgery with dura  
mater implantation.
3. FAMILIAL CJD
Definite or probable CJD plus definite or probable CJD in a first degree relative; and/or 
Neuropsychiatric disorder plus disease-specific PrP gene mutation.
From https://www.cdc.gov/prions/cjd/diagnostic-criteria.html
Figure 1: MRI Brain without Contrast
Diffusion- weighted image showing high 
signal intensity on the right caudate nucleus. 
See arrow.
ROS
1.  Chest pressure with radiation down arms 
2.  Decreased appetite and 20-pound weight 




2. Gastroesophageal reflux disease (GERD)
3. Depression
4. Hyperlipidemia
5. Allergic rhinitis 
6. Attention deficit disorder (ADD)
PSHx
1. Remote vasectomy 
2.  Cataract extraction with intraocular lens 
implant in 2016
MEDHx
1. Sertraline 150 mg
2. Atorvastatin 40mg 
3. Fexofenadine 180 mg
4. Fluticasone propionate 50 mcg 
5. Multivitamin
FMHx
1.  History of depression and psychiatric 
illnesses on his mother’s side
2.  His father had diabetes and hyperlipidemia
3.  No family history of cardiac or 
cerebrovascular disorders.
SOCHx
1.  Previous tobacco use until 6 years ago, 
having smoked a pack a day for 30 years.
2.  He rarely uses alcohol and denies ever 
using recreational drugs.
CASE REPORT
ANXIETY AND DEPRESSION WITH 
SUICIDAL IDEATION
•  A 53-year-old male presenting to the ED with 
the above chief complaint.
•  Reports vivid images of standing in the street 
waiting to be hit by a car. 
•  His anxiety and depression have been 
affecting his daily activities and relationships.
•  He describes difficulty concentrating and 
angry outbursts. 
•  He recently quit his job of 28 years as a 
bakery manager at a local super market due 
to inability to concentrate, follow directions, 
and mood swings.
•  Six days prior to presentation, the patient 
drove through a red light and ran off the road 
but did not have any recollection of why or 
how this happened. He was uninjured and he 
hit nothing. However, this car accident 
worsened his anxiety. He no longer drives.
•  His second wife, who is present with him 
today, states that he has started talking to 
himself. In addition, wife reports that he has 
periods where he seems distant, absent for 
several seconds and he does not 
communicate. 
•  Patient started noticing progressively 
worsening depression over the past 4 months.
•  His family doctor has steadily increased his 
sertraline over the past five months without 
improvement. 
•  His abusive father recently died further 
worsening his anxiety and depression. 
•  Patient has never had any hospitalizations for 
anxiety or depression in the past or had any 
suicidal ideations in the past.
CLINICAL COURSE
•  Initial laboratory testing including toxicology is unremarkable. 
•  Due to the chest discomfort, the patient was medically cleared after two 
negative troponins, normal ECG, and normal chest X-ray. 
•  He signed a voluntary commitment for psychiatric treatment and was 
admitted to the behavioral health unit for psychiatric treatment. 
•  Over the next few days, the patient continues to experience depression 
and anxiety. He no longer endorses suicidal ideation, but now experiences 
paranoia. This progresses over the next few days to the point where the 
patient requires constant redirecting. He grows increasingly disoriented, 
answering unrelated to questions but speaking clearly. He receives several 
different antidepressants and antipsychotics without any improvement  
in symptoms.
•  Due to the progression of illness, the patient is seen by the medical team, 
though there is no significant change in his examination, and it is felt that 
his neurologic status is related to his psychiatric illness. Neurology is 
consulted after staff observes brief episodes where his arm dropped, and 
he was staring without responding. His wife notes episodes prior to this 
admission including twitching like movements in his arms. The patient’s 
speech progresses to confabulation. A Magnetic Resonance Imaging (MRI) 
brain with and without contrast and Electroencephalogram (EEG) are 
ordered. At this point the patient is cooperative, but has limited speech 
and frequently fails to answer questions. Strength and sensation remain 
intact, though the patient now has mildly increased tone.
CASE CONCLUSION
•  MRI demonstrates DWI high signal intensity/restricted diffusion in bilateral 
cerebral cortices and basal ganglia, more pronounced on the right. This 
finding can be seen with Creutzfeldt-Jakob (CJD) disease, encephalitis, 
and toxic/metabolic processes, and unlikely diagnosis of hypoxic/ischemic 
injury. Recommendation is made for correlation  
with clinical history, EEG and CSF. See MRI image.
•  The EEG is abnormal and shows slowing over the right hemisphere with 
some anterior rhythmic slowing that are consistent with a diffuse 
encephalopathy. 
•  CSF demonstrates large amount of T-tau protein and is positive for CJD 
protein 14-3-3. 
•  These tests confirm the diagnosis of Creutzfeldt-Jakob disease. 
•  The patient continues to decline cognitively, eventually becoming delirious, 
with incoherent speech and lack of communication. The patient is moved 
to hospice and eventually expires.
DISCUSSION
CJD is one of the major causes of rapid progressive dementia.3 CJD is a fatal neurodegenerative disease affecting humans and 
animals. It is caused by an abnormal accumulation and/or metabolism of prion proteins. The mutation in the prion protein 
results in the production of protease-resistant prion protein, which causes nerve damage.3 It is believed that the protein may 
cause small vacuoles in neuronal cell bodies, axons, dendrites which may be the cause of nerve damage resulting in the various 
clinical presentations. One person is affected per one million per year. There are no gender biases. It typically occurs in people 
in their 5th–7th decades, average age 60 years. CJD can be transmitted by sporadic, familial, iatrogenic, and variant means. 
CJD occurring without a known source is called sporadic CJD which is the most common cause.3 Iatrogenic CJD may be 
related to cornea transplantation, dural grafts, application of infected electrode injections of growth hormone or gonadotropin 
obtained from cadavers. Variant type of CJD is characterized by psychiatric symptoms at an earlier stage with a longer clinical 
deterioration and death at a younger age. Our patient may have had this variant /sporadic form. Nearly one third of cases of 
variant CJD start with depression, emotional lability, behavioral changes, loss of appetite, and insomnia.4,5
The differential diagnosis for altered mental status and abnormal neurologic examination is quite extensive. Many causes of 
altered mentation are reversible or can be improved with appropriate diagnosis and treatment such as heavy metal toxicity, 
thyroid disorders, viral or bacterial encephalopathies and vitamin deficiencies.6 Diagnosis will rarely be completed in the 
emergency room. However, it is crucial to note the rapidly progressing dementia symptoms and to begin work-up in consultation 
with other specialties including neurology.6,7
When evaluating a patient with suspected CJD or other rapidly progressive dementia, the work up should include a complete 
blood count (CBC), comprehensive metabolic panel (CMP), thyroid function and computed tomography (CT) of the brain. In 
consultation with neurology, other diagnostic studies may be warranted.8 Those may include serology for neurosyphilis, 
paraneoplastic antibodies, limbic encephalitis. MRI of the brain, with axial DWI diffusion weighted imaging, FLAIR- fluid 
attenuated inversion recover, EEG, CSF, CJD 14-3-3, S100b, abeta and tau proteins may be ordered.5,9
CJD anomalies on MRI are often patchy, extensive, but should involve more than one cortical region/area that is not vulnerable 
to artefactual signal change.10 Thalamic signal change may be diffuse or have emphasis in dorsal/medial aspects. MRI is more 
than 90% effective in the diagnosis of sporadic CJD. DWI often shows hyper densities basal ganglia. However, other areas may 
be affected depending on clinical presentation.10
EEG anomalies in CJD often include lateralized or focal periodic sharp waves representing cerebral dysfunction.10 Lumbar 
puncture is used to evaluate CSF for specific proteins.5,11 But the cost and availability of these tests, limit the ability to rapidly 
obtain them.11 Rapid clinical progression occurs from normally functioning to death in approximately one year for most diagnosed 
CJD patients. The patient in this case, expired in approximately 7 months from his worsening anxiety and depression. This is a 
100% fatal disease. Definitive diagnosis still involves prion protein identification in post mortem brain tissue.11
CONCLUSION
This case is important to the ED because it highlights the importance of the history of the present illness.  In this case, the rapid 
loss of ADLs with behavioral changes should increase suspicion for a medical etiology for the patient’s symptoms. Although the 
physical exam was benign initially, there was a progressive decline in neurologic status in the HPI.  In the event of any 
neurologic symptoms and/or rapid loss of functioning of ADLS, it is important to consider the many causes of rapid progressive 
dementia and to initiate the work-up in consultation with neurology. Ultimately, the outcome for the patient was unchanged; 
however, the diagnosis was possibly delayed by being in a psychiatric unit.  Many of the other causes of rapidly progressive 
dementia can be reversed or slowed with appropriate treatment.
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